MetaCap

New Providence Acquisition III (NPAC) vs Prenetics Global (PRE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Prenetics Global is the larger company by market cap ($429.3 million vs $403.1 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

NPAC versus PRE key metrics
MetricNPACPRE
Share price$10.50$22.00
Market cap$403.10M$429.31M
1-day change+0.10%-2.09%
YTD return—+39.68%
1-year return—+48.55%
5-year return—-80.83%
P/E ratio (TTM)43.75—
EPS (TTM)$0.24$-3.10
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$10.54$27.24
52-week low$10.21$11.37
Distance from 52-week high-0.38%-19.24%
Analyst consensus—none
Avg. price target upside—+63.00%
Average volume85.00K241.01K
Shares outstanding30.89M17.93M
Employees—98
SectorFinanceFinance
IndustryBlank ChecksBlank Checks

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About New Providence Acquisition III

NPAC stock →

New Providence Acquisition Corp. III does not have significant operations.

Finance · Blank Checks

About Prenetics Global

PRE stock →

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand.

Finance · Blank Checks · 98 employees

NPAC vs PRE FAQ

Which is bigger, New Providence Acquisition III or Prenetics Global?

Prenetics Global (PRE) is larger, with a market capitalization of $429.31M compared with $403.10M for New Providence Acquisition III (NPAC).

Are New Providence Acquisition III and Prenetics Global in the same industry?

Yes. Both are classified in the Blank Checks industry within the Finance sector.

More comparisons